In two phase 2b trials, RNA interference agents were associated with reductions in triglycerides compared with placebo for patients with mixed hyperlipidemia.The final results of the MUIR trial of ...

Hyperlipidemia also occurs in patients with autoimmune diseases. Immunosuppressant drugs are the leading cause of hyperlipidemia, with contributions from genetics, diabetes and renal disease.

However, the diagnosis rate of hyperlipidemia in Taiwan is estimated to be only about 52 percent, lower than 80 percent in Japan and 63 percent in South Korea, Huang said. The diagnosis rate is ...

Hyperlipidemia in the Elderly - Medscape - Apr 15, 2003. Tables. References. Authors and Disclosures. Authors and Disclosures Author(s) Mark E Williams, MD .

Overall, we found that rates of hyperlipidemia screening and statin prescription were suboptimal; the gaps were large enough to recommend broad, rather than targeted, efforts to close them.

We report on a series of nine patients with hyperlipidemia and either chronic myeloid leukemia or the hypereosinophilic syndrome, in eight of whom plasma lipid levels normalized within one month ...

Promising results for hyperlipidemia treatment reduces risk of cardiovascular events. Graciela Gutierrez. 713-798-4710. Houston, TX - May 28, 2024. Share this article. Content.

Few patients with hyperlipidemia receive recommended thyroid screening Date: November 13, 2013 Source: Boston University Medical Center Summary: Despite current guidelines that recommend newly ...

Hyperlipidemia, which is having blood cholesterol and/or triglyceride levels that are too high, is a risk factor for many forms of cardiovascular disease. Regular physical activity, when combined ...